Atlas of Thyroid and Neuroendocrine Tumor Markers

This book highlights the increase in thyroid tumors and NET and demonstrates the growing importance of circulating markers in diagnosis as well as treatment and follow-up. Dramatic technical improvements have heightened the clinical impact of well-established, conventional biochemical markers. In ad...

Celý popis

Uložené v:
Podrobná bibliografia
Médium: Elektronický zdroj E-kniha
Jazyk:English
Vydavateľské údaje: Cham : Springer International Publishing, 2018.
Vydanie:1st ed. 2018.
Predmet:
ISBN:9783319625065
On-line prístup: Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

MARC

LEADER 00000nam a22000005i 4500
003 SK-BrCVT
005 20220618115338.0
007 cr nn 008mamaa
008 180123s2018 gw | s |||| 0|eng d
020 |a 9783319625065 
024 7 |a 10.1007/978-3-319-62506-5  |2 doi 
035 |a CVTIDW07040 
040 |a Springer-Nature  |b eng  |c CVTISR  |e AACR2 
041 |a eng 
245 1 0 |a Atlas of Thyroid and Neuroendocrine Tumor Markers  |h [electronic resource] /  |c edited by Luca Giovanella. 
250 |a 1st ed. 2018. 
260 1 |a Cham :  |b Springer International Publishing,  |c 2018. 
300 |a XII, 249 p. 41 illus., 30 illus. in color.  |b online resource. 
500 |a Medicine  
516 |a text file PDF 
520 |a This book highlights the increase in thyroid tumors and NET and demonstrates the growing importance of circulating markers in diagnosis as well as treatment and follow-up. Dramatic technical improvements have heightened the clinical impact of well-established, conventional biochemical markers. In addition, more recent genetic and molecular approaches have provided innovative molecular markers. In this context, effective communication between clinicians and laboratory physicians/scientists is essential in allowing all those involved to fully profit from these exciting advances. In this comprehensive, up-to-date book, authors from different laboratory and clinical areas link laboratory and clinical topics. Analytical problems such as interferences, false-negative and false-positive results are discussed in depth, and flow-charts offer insights into identifying and avoiding them. Illustrated clinical cases detail the clinical role and limitations of different tumor markers. Lastly, it explores health technology assessment and economic issues. This is a valuable resource for endocrinologists, oncologists, nuclear medicine physicians, scientists and technologists who want to keep abreast of the latest developments. 
650 0 |a Endocrinology . 
650 0 |a Laboratory medicine. 
650 0 |a Nuclear medicine. 
650 0 |a Radiotherapy. 
650 0 |a Pathology. 
856 4 0 |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-62506-5  |y Vzdialený prístup pre registrovaných používateľov 
910 |b ZE04320 
919 |a 978-3-319-62506-5 
974 |a andrea.lebedova  |f Elektronické zdroje 
992 |a SUD 
999 |c 273059  |d 273059